Tecsys Stock Earnings Reports

Tecsys reported a strong fiscal 2025 with continued SaaS momentum and product traction, but provided conservative near-term SaaS guidance while increasing investments in R&D and marketing. Key financials: Q4 revenue $46.6M (record quarter), SaaS revenue up 29% YoY to $18.4M in Q4 and $67.1M for the year (also +29% YoY); core product Elite up 32%; professional services Q4 record $16.2M and record PS backlog $49M (up 52% YoY). Q4 gross margin 51% (vs. 47% LY), net profit $1.7M, adjusted EBITDA $4.3M. FY total revenue $176.5M (+3% YoY; +12% ex-hardware). Balance sheet: $39.3M cash/short-term investments, no debt; $6.9M share buybacks in FY25; board approved quarterly dividend of $0.085/share. Strategic highlights: Roche rollout progressing to 1,000+ sites, Gartner Challenger recognition (14th consecutive time), new India subsidiary acquisition to add development/support capacity, largest user conference to date where two product innovations were announced (ESL+ and Tecsys IQ — an AI/data layer built on Databricks). Guidance and priorities: fiscal 2026 guidance calls for SaaS revenue growth of 20–22% and total revenue growth of 8–10%; adjusted EBITDA margin guidance trimmed to 8–9% (driven by higher R&D/marketing and FedRAMP and India-related costs) with expected adjusted EBITDA growth of 20–30%. Management notes continued strong pipeline and buyer intent, a focus on health-care and selected distribution verticals, variability in professional services revenue timing, and vigilance around macro/policy risks (e.g., Medicaid discussions) though no current slowdown in customer activity.